Has Narlin Beaty, MD received payments from drug or device companies?

Yes. Drug and device makers reported $471,811 in general payments to Narlin Beaty, MD across 594 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Narlin Beaty, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Narlin Beaty, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Narlin Beaty, MD

Neurological Surgery · Tallahassee, FLNPI 1184859530

Payments from drug & device makers

$471,811in general payments, 2019–2025

Across 594 payments — averaging $794.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$371K
AstraZeneca$47K
Tanabe Pharma America, Inc.$46K
Imperative Care, Inc$3K
Medtronic$2K
Johnson & Johnson$393
plus $2K from 50 others

What the payments were for

Consulting fees$313,13674%
Speaking & faculty fees$39,4909%
Travel & lodging$62,49615%
Food & beverage$7,8602%
Education$320%
Ownership interest$130%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	378	$370,562
AstraZeneca(2 entities)	46	$47,230
Tanabe Pharma America, Inc.	5	$46,282
Imperative Care, Inc	32	$3,249
Medtronic(2 entities)	25	$1,782
Johnson & Johnson(2 entities)	19	$393
Ulrich Medical USA, Inc.	1	$190
Portola Pharmaceuticals, LLC	5	$159
Microtransponder, Inc.	2	$126
Microvention, Inc.	2	$119
Si-bone, Inc.	6	$107
Cerapedics Inc.	2	$96
Silk Road Medical, Inc.	5	$94
Globus Medical	1	$91
Chiesi USA, Inc.	6	$87
Kls-martin L.p.	4	$76
CGG Medical Inc	2	$64
Penumbra, Inc.	3	$59
Boston Scientific	3	$55
Orthofix Medical, Inc.	2	$51
Amneal Pharmaceuticals LLC	2	$50
Saol Therapeutics Inc.	2	$49
Carlsmed, Inc.	1	$49
KCI USA, Inc.	1	$39
Servier Pharmaceuticals LLC	2	$38
Inspire Medical Systems, Inc.	2	$37
Abbott	2	$37
Inspiremd Ltd	2	$35
Nevro Corp.	2	$33
Biocomposites Inc	1	$33
Novo Nordisk	1	$32
Cordis US CORP.	1	$31
Ceribell, Inc.	1	$30
Integra Lifesciences Corporation	2	$29
Mallinckrodt Enterprises LLC	1	$29
AbbVie	2	$29
Seaspine Orthopedics Corporation	1	$29
Bioventus LLC	1	$25
Kerecis Limited	1	$24
Genentech USA, Inc.	1	$22
Tersera Therapeutics LLC	1	$21
Smith+Nephew	1	$20
Spinal Elements, Inc.	1	$20
Novocure Inc.	1	$19
Piramal Critical Care	1	$19
Acelrx Pharmaceuticals, Inc.	1	$18
Surgalign Spine Technologies, Inc.	1	$16
Convatec Inc.	1	$16
UCB, Inc.	1	$15
Axogen	1	$13
Irras USA, Inc.	1	$13
Arteriocyte Medical Systems, Inc.	1	$13
Flowonix Medical Incorporated	1	$13
Elutia, Inc.	1	$13
Cardiva Medical, Inc.	1	$12
Arbor Pharmaceuticals, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SURPASS EVOLVE$223,048
SURPASS$124,838
ANDEXXA$46,733
1488, IDEAL EYES$14,700
UNIVERSAL NEURO 3$2,419
CD HORIZON$1,094
NEURO$712
TARGET$581
PROCUITY$483
TREVO$201
INFINITY$145
CATALYST$145

How this compares

$471,811 in reported general payments places this provider in the 90th percentile of 556 neurological surgery providers in Florida.

See all neurological surgery providers in Florida →

Medicare billing

Part B allowed, 2024

$215,300

Medicare patients

399

Services billed

911

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Atorvastatin Calcium	32	$607
Celecoxib	13	$466
ClopidogrelClopidogrel Bisulfate	36	$341
Levetiracetam	12	$299
Methocarbamol	11	$174
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	25	$164
Methylprednisolone	14	$110
Tramadol Hcl	18	$94
Oxycodone Hcl	13	$91

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Tallahassee

Griffin BaumTallahassee$494K
Stephen ParkerJacksonville$18.7M
Ira GoodmanOrlando$10.4M
Eric PetersonMiami$10.1M
Brian SnellingBoca Raton$10M
Kim ManwaringOrlando$5M
Ricardo HanelJacksonville$3.8M
Brian HohGainesville$3.7M
Paul SawinWinter Park$3M
John MainOcala$2.8M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →